Taiwan Shifts Focus to Homegrown COVID-19 Vaccine as Global Supplies Slump
Click the image below to enlarge the infographic.
- Taiwan is shifting its focus to a locally manufactured COVID-19 vaccine to speed up its inoculation program as the Island and other countries struggle to secure global supplies
- The locally produced COVID-19 vaccine from Medigen Vaccine Biologics was rolled out last week, with President Tsai Ing-wen receiving her first shot of the two-dose vaccine Monday
- Medigen's vaccine was developed in partnership with the National Institutes of Health in the United States and is based on a technology called recombinant protein, which uses part of the coronavirus protein to include an immune response
- Health authorities in Taiwan cleared the vaccine for emergency use in July after only phase two clinical trials in Taiwan
- Despite the lack of efficacy data on the vaccine, more than 600,000 people in Taiwan have received the shot in the last week